AGEN

Agenus’ (AGEN) CEO Dr. Garo Armen on Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Christine Klaskin Thank you, Jonae. Good morning, everyone, and thank you for joining us on today’s call. Some of the statements I will be making are also contained in the press release issued this morning…. moreView todays social media effects on AGENView the latest stocks trending across Twitter. Click to view dashboardSee who Agenus is hiring […]

Agenus Reports First Quarter 2014 Financial Results

[Business Wire] – Agenus Inc. , an immuno-oncology company developing a portfolio of checkpoint modulators , heat shock protein vaccines and adjuvants, today announced its financi moreView todays social media effects on AGENView the latest stocks trending across Twitter. Click to view dashboardSee who Agenus is hiring next, click here to view […]

Update on GSK’S MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Non-Small Cell Lung Cancer

[Business Wire] – Agenus Inc. today announced that GlaxoSmithKline’s MAGRITi study, a Phase 3 randomized, blinded, placebo-controlled MAGE-A3ii cancer immunotherapeutic trial in non-small cell lung cancer patients, which contains Agenus’QS-21 Stimulon® moreView todays social media effects on AGENView the latest stocks trending across Twitter. Click to view dashboardSee who Agenus is hiring next, click here to view […]

Faruqi & Faruqi, LLP Launches An Investigation Against Agenus Inc. (AGEN) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors

[PR Newswire] – NEW YORK, March 14, 2014 /PRNewswire/ — Juan E. Monteverde , a partner at Faruqi & Faruqi, LLP , a leading national securities firm headquartered in New York City, is investigating the Board of Directors … moreView todays social media effects on AGENView the latest stocks trending across Twitter. Click to view dashboardSee who Agenus is hiring […]